UK & Europe
In-depth coverage of regulatory change and licensing frameworks across the UK & EU.
UK & Europe · page 6
- Medical Cannabis
Germany Expands Its Medical Cannabis Import Cap as Australia Moves to Cut Back
Australia and Germany are moving in opposite directions on medical cannabis imports, as both scramble to deal with the runaway growth of their medical cannabis markets.
- Industry Trends
Early Results From Züri Can Pilot Bolster Case for Switzerland’s Federal Legalisation
Zurich’s flagship adult-use cannabis trial, Züri Can, could now run until 2028 after city officials applied this week to extend the project by two years, citing strong early results in reducing illicit sales and promoting safer consumption.
- UK & Europe
‘Significant Variation in Standards’ Found Across UK Medical Cannabis Pharmacies as ACMD Review Call Closes
The Advisory Council on the Misuse of Drugs (ACMD) has closed its latest call for evidence into the impact of medical cannabis legalisation, in what will mark the most comprehensive review of the UK’s cannabis-based products for medicinal use (CBPM) framework since it was introduced in 2018.
- UK & Europe
What Will ‘Czech Trump’ Mean for the Country’s Cannabis Industry?
The Czech Republic, long considered one of Europe’s most progressive countries on cannabis and wider drug reform, is entering a period of political transition following its parliamentary election earlier this month.
- UK & Europe
Legal Sources Now the First Choice for Cannabis Users in Germany
Since Germany’s Cannabis Act (CanG) came into force on 1 April 2024, much has changed regarding what was once the country’s most widely used illegal drug.
- UK & Europe
Cannabis Researchers Call for Implementation of Second Pillar of the KCanG
When Germany introduced the Recreational Cannabis Act (KCanG), it not only legalised home cultivation and consumption for adults but also laid the groundwork for scientifically monitored pilot projects allowing the legal sale of cannabis at authorised distribution points.
- UK & Europe
Germany Advances MedCanG Amendments to Restrict Prescriptions and Telemedicine Use
Just a week after the first official data on the impact of Germany’s cannabis reforms was published, the Federal Cabinet approved proposals to restrict medical cannabis prescriptions across the country.
- UK & Europe
‘No One Expected the Surge’: Grunhorn on How Telemedicine Took German Medical Cannabis by Storm
Since April 2024, Germany has been firmly cemented at the centre of the global cannabis conversation, and for good reason.
- UK & Europe
Spain Becomes Latest European Medical Cannabis Market as First National Rules Given Green Light
First published on Cannabis Health In a landmark decision, Spain’s Council of Ministers has approved a Royal Decree regulating the medical use of cannabis-based preparations in hospital settings, marking the country’s first comprehensive framework for cannabis-derived medicines.
- Medical Cannabis
Import Approvals Paused as Germany Hits 2025 Medical Cannabis Limit
The Federal Institute for Drugs and Medical Devices (BfArM) has announced that Germany’s estimated annual demand for medical cannabis in 2025 has already been reached, leading to a temporary suspension of new import licences.
- Medical Cannabis
German Political Divide Deepens Over Interim Cannabis Report Findings
Last week, Business of Cannabis reported on the publication of Germany’s first official evaluation of its Recreational Cannabis Act (KCanG) and the early data suggesting limited social and health impacts from legalisation.
- UK & Europe
What Does the First Official Data on Germany’s Cannabis Reforms Show?
Germany’s booming cannabis market, which Prohibition Partners now estimates to be worth around €670m, is entering uncertain and potentially treacherous territory.
